Compared to the non-tumor controls, cholangiocarcinoma, hepatocellular carcinoma, and gastric carcinoma patients presented significantly elevated serum TGFBI levels, with cholangiocarcinoma cases having the highest values. Here, TGFBI is linked to hepatocellular carcinoma.